Operating at millimetRE-wave frequencies introduces a set of engineering challenges that extend far beyond traditional radio frequency testing ...

LCGC International salutes Jack Henion and Bob W.J. Pirok, winners of the 19th annual LCGC Lifetime Achievement and Emerging ...

LIGHT’s Q4 2025 sales are projected at $78–$80 million, up 67% YoY, with defense programs like Israel’s Iron Beam as key catalysts. Find out why LASR is a Buy.

Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic ...

Hårklinikken’s clinically backed formula is helping women regrow hair through a multifactorial approach leading to long term results.

MACOM Technology Solutions Holdings, Inc. ( MTSI) Q1 2026 Earnings Call February 5, 2026 8:30 AM EST Welcome to MACOM's First Fiscal Quarter 2026 Conference Call. This call is being recorded today, ...

Sanofi has received Breakthrough Therapy designation from the U.S. FDA and orphan drug designation from Japan’s Ministry of Health, Labour and Welfare for rilzabrutinib (Wayrilz) in warm autoimmune ...

A research team led by Prof. Zhang Tianshu from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences ...

Higher levels of integration and ingenious power-conversion architectures are enabling simpler, denser, more efficient ...

A wide of array of advanced controllers arrived in 2025, marked by high integration and enhanced intelligence in solutions ...

But we do think that the CT and the NPO sort of transition is a benefit to MACOM Technology Solutions Holdings, Inc. I'll ...